HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liangzhi Xie Selected Research

Surface-Active Agents (Surfactants)

7/2003Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liangzhi Xie Research Topics

Disease

13COVID-19
05/2024 - 01/2020
3Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 10/2022
3Neoplasms (Cancer)
11/2023 - 01/2023
3Virus Diseases (Viral Diseases)
12/2020 - 12/2002
2Infections
01/2023 - 01/2017
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2022 - 04/2016
2Hemorrhage
11/2022 - 09/2021
2Communicable Diseases (Infectious Diseases)
09/2022 - 05/2022
2Disease Progression
01/2022 - 01/2011
1Weight Loss (Weight Reduction)
05/2024
1Sarcoma (Soft Tissue Sarcoma)
12/2023
1Chronic Obstructive Pulmonary Disease (COPD)
11/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023
1Melanoma (Melanoma, Malignant)
11/2023
1Colonic Neoplasms (Colon Cancer)
11/2023
1Bell Palsy (Bell's Palsy)
10/2023
1Pneumonia (Pneumonitis)
02/2023
1Inflammation (Inflammations)
01/2023
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022
1Hemophilia A (Haemophilia)
11/2022
1Breakthrough Infections
11/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022
1Esophageal Squamous Cell Carcinoma
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Ebola Hemorrhagic Fever
01/2017

Drug/Important Bio-Agent (IBA)

9Monoclonal AntibodiesIBA
01/2024 - 04/2016
6VaccinesIBA
02/2023 - 01/2020
4Neutralizing AntibodiesIBA
01/2023 - 01/2011
3AntibodiesIBA
05/2024 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
12/2023 - 10/2022
2SCTV01C vaccineIBA
10/2023 - 01/2023
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2023 - 01/2023
2Biosimilar PharmaceuticalsIBA
06/2023 - 11/2022
2COVID-19 VaccinesIBA
01/2023 - 01/2022
2Rituximab (Mabthera)FDA Link
12/2022 - 12/2022
1IgYIBA
05/2024
1Fluorouracil (Carac)FDA LinkGeneric
01/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024
1Irinotecan (Camptosar)FDA LinkGeneric
01/2024
1Therapeutic UsesIBA
11/2023
1Interferon-betaIBA
11/2023
1InterferonsIBA
11/2023
1Immune Checkpoint InhibitorsIBA
11/2023
1Bevacizumab (Avastin)FDA Link
06/2023
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2023
1Factor VIII (Coagulation Factor VIII)IBA
11/2022
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
11/2022
1Adalimumab (Humira)FDA Link
11/2022
1NanovaccinesIBA
05/2022
1Polysaccharides (Glycans)IBA
05/2022
1Growth Factor ReceptorsIBA
01/2022
1Single-Domain AntibodiesIBA
01/2022
1upanovimabIBA
10/2021
1AntigensIBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
12/2020
1Proteins (Proteins, Gene)FDA Link
12/2020
1Glycoproteins (Glycoprotein)IBA
01/2017
1Surface-Active Agents (Surfactants)IBA
07/2003
1BuffersIBA
07/2003
1Glucose (Dextrose)FDA LinkGeneric
12/2002
1Glutamine (L-Glutamine)FDA Link
12/2002
1Lactic Acid (Lactate)FDA LinkGeneric
12/2002

Therapy/Procedure

8Therapeutics
05/2024 - 01/2020
2Injections
11/2022 - 09/2021
2Intravenous Infusions
09/2022 - 01/2022
1Immunotherapy
01/2022
1Drug Therapy (Chemotherapy)
01/2022